Amicus Therapeutics Inc. (NASDAQ:FOLD): An Opportunity for Fundamental Investors?
Amicus Therapeutics Inc. (NASDAQ:FOLD) previous close was $10.20 while the outstanding shares total 264.37M. The firm has a beta of 1.11. FOLD’s shares traded lower
Amicus Therapeutics Inc. (NASDAQ:FOLD) previous close was $10.20 while the outstanding shares total 264.37M. The firm has a beta of 1.11. FOLD’s shares traded lower
Amicus Therapeutics Inc. (NASDAQ:FOLD) shares fell to a low of $10.645 before closing at $10.72. Intraday shares traded counted 2.12 million, which was 21.65% higher
Amicus Therapeutics Inc. (NASDAQ:FOLD) shares fell to a low of $9.96 before closing at $10.38. Intraday shares traded counted 2.25 million, which was 20.07% higher
Amicus Therapeutics Inc. (NASDAQ:FOLD) shares fell to a low of $9.20 before closing at $9.26. Intraday shares traded counted 2.32 million, which was 22.86% higher
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne